Maximus (MMS) Stock Price, News & Analysis

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MMS shares.
View MMS analyst ratings or view top-rated stocks.

2 Wall Street analysts have issued 1 year price targets for Maximus' shares. Their MMS share price targets range from $102.00 to $102.00. On average, they expect the company's stock price to reach $102.00 in the next year. This suggests a possible upside of 27.5% from the stock's current price.
View analysts price targets for MMS or view top-rated stocks among Wall Street analysts.

Maximus' stock was trading at $83.86 at the beginning of the year. Since then, MMS stock has decreased by 4.6% and is now trading at $80.03.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our MMS earnings forecast.

Maximus will be holding an earnings conference call on Thursday, May 9th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Maximus, Inc. (NYSE:MMS) issued its quarterly earnings results on Wednesday, February, 7th. The health services provider reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.06. The health services provider had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 3.73% and a trailing twelve-month return on equity of 15.68%. The business's quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.94 earnings per share.

Maximus declared a quarterly dividend on Friday, April 5th. Shareholders of record on Wednesday, May 15th will be paid a dividend of $0.30 per share on Friday, May 31st. This represents a $1.20 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date is Tuesday, May 14th.
Read our dividend analysis for MMS.

Maximus (NYSE:MMS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 1.49%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 39.74%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 20.98% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

ETFs with the largest weight of Maximus (NYSE:MMS) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Nuveen Small Cap Select ETF (NSCS), Fidelity Low Volatility Factor ETF (FDLO), Adaptive Growth Opportunities ETF (AGOX), Vanguard Russell 2000 Growth ETF (VTWG) and iShares Russell 2000 Growth ETF (IWO).

Maximus updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of 5.200-5.500 for the period, compared to the consensus EPS estimate of 4.240. The company issued revenue guidance of $5.1 billion-$5.2 billion, compared to the consensus revenue estimate of $5.1 billion.

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

Maximus' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.16%), Reinhart Partners LLC. (0.38%), Chatham Capital Group Inc. (0.06%), Rowlandmiller & PARTNERS.ADV (0.05%), Bridge City Capital LLC (0.04%) and State of Michigan Retirement System (0.02%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michael J Warren, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Teresa Weipert.
View institutional ownership trends.

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.